GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Lotus Bio-Technology Development Corp (OTCPK:LBTD) » Definitions » Total Current Liabilities

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Total Current Liabilities : $0.07 Mil (As of Dec. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Lotus Bio-Technology Development Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Lotus Bio-Technology Development's total current liabilities for the quarter that ended in Dec. 2017 was $0.07

Lotus Bio-Technology Development Total Current Liabilities Historical Data

The historical data trend for Lotus Bio-Technology Development's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Bio-Technology Development Total Current Liabilities Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Total Current Liabilities
Get a 7-Day Free Trial 0.01 0.03 0.05 0.07 0.08

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 - - 0.07

Lotus Bio-Technology Development Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Lotus Bio-Technology Development's Total Current Liabilities for the fiscal year that ended in Mar. 2017 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.074+0.006
+Other Current Liabilities+Current Deferred Liabilities
=0.001+0
=0.08

Lotus Bio-Technology Development's Total Current Liabilities for the quarter that ended in Dec. 2017 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.067+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Lotus Bio-Technology Development Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Lotus Bio-Technology Development's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Lotus Bio-Technology Development Corp (OTCPK:LBTD) » Definitions » Total Current Liabilities
Comparable Companies
BOM:538858 NSE:BOHRA FSE:4995 BOM:530433 TSX:KRN BOM:524687 SNES ROCO:8496 WAR:BIK BOM:540071 TSXV:FGR CVAT BOM:503776 BOM:537292 BOM:531862 BOM:590128 BOM:539470 SGX:1H2 NSE:AGROPHOS BOM:524808
Traded in Other Exchanges
N/A
Address
108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Website
http://www.starflick.com
Lotus Bio-Technology Development Corp is a biotechnology development company. It focuses on specializing in the refining of organic materials and the production of natural consumer-related products. It is exploring opportunities in the organic growth and farming sector in China and provides local customers the real organic food products with affordable prices and guarantees that all of them will be produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones, or other dangerous chemicals. All the operation is primarily functioned through the region of China.
Executives
Zoltan Nagy other: FX President/CEO 1361 PELTIER DR., POINT ROBERTS WA 98281